Roger E. Susi

Insider Reports History

Reporting-owner location: Orlando, FL
Latest reporting-owner signature: /s/ Roger E. Susi
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Roger E. Susi

Form 4 holding CEO, President, Chairman, Director, 10%+ Owner

IRADIMED CORP

Security class: Common Stock
Shares / value: 2,162,500
Estimated value: $198,755,375
Report date: 01 Jun 2026
Price: $91.91
Ownership: By Phillip Susi 2008 Dynasty Trust

Form 4 holding CEO, President, Chairman, Director, 10%+ Owner

IRADIMED CORP

Security class: Common Stock
Shares / value: 2,062,500
Estimated value: $198,536,250
Report date: 01 Jun 2026
Price: $96.26
Ownership: By Matthew Susi 2008 Dynasty Trust

Form 4 holding CEO, President, Chairman, Director, 10%+ Owner

IRADIMED CORP

Security class: Common Stock
Shares / value: 162,950
Estimated value: $15,685,567
Report date: 01 Jun 2026
Price: $96.26
Ownership: By Roger E. Susi Revocable Trust

Insider Reports Filed by Roger E. Susi

4 IRMD

IRADIMED CORP

Report period: 01 Jun 2026
Transactions: 4
Transaction value: -$226,507
Accepted by SEC: 02 Jun 2026, 14:26
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 26 May 2026
Transactions: 4
Transaction value: -$691,044
Accepted by SEC: 28 May 2026, 15:08
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 May 2026
Transactions: 6
Transaction value: -$657,265
Accepted by SEC: 20 May 2026, 16:38
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 11 May 2026
Transactions: 5
Transaction value: -$631,341
Accepted by SEC: 13 May 2026, 16:30
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 04 May 2026
Transactions: 7
Transaction value: -$642,862
Accepted by SEC: 06 May 2026, 13:51
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Apr 2026
Transactions: 7
Transaction value: -$657,709
Accepted by SEC: 30 Apr 2026, 14:30
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 20 Apr 2026
Transactions: 6
Transaction value: -$694,124
Accepted by SEC: 22 Apr 2026, 15:03
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Apr 2026
Transactions: 5
Transaction value: -$697,189
Accepted by SEC: 15 Apr 2026, 14:37
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Apr 2026
Transactions: 5
Transaction value: -$717,208
Accepted by SEC: 07 Apr 2026, 15:26
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 30 Mar 2026
Transactions: 3
Transaction value: -$712,614
Accepted by SEC: 01 Apr 2026, 15:35
Role: CEO, President, Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 23 Mar 2026
Transactions: 5
Transaction value: -$752,609
Accepted by SEC: 25 Mar 2026, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 16 Mar 2026
Transactions: 3
Transaction value: -$762,970
Accepted by SEC: 18 Mar 2026, 14:10
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 09 Mar 2026
Transactions: 2
Transaction value: -$750,475
Accepted by SEC: 10 Mar 2026, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Mar 2026
Transactions: 2
Transaction value: -$737,919
Accepted by SEC: 09 Mar 2026, 16:30
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 26 Jan 2026
Transactions: 2
Transaction value: -$503,255
Accepted by SEC: 27 Jan 2026, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 20 Jan 2026
Transactions: 3
Transaction value: -$509,225
Accepted by SEC: 21 Jan 2026, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 12 Jan 2026
Transactions: 2
Transaction value: -$487,231
Accepted by SEC: 13 Jan 2026, 16:20
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 05 Jan 2026
Transactions: 5
Transaction value: -$488,417
Accepted by SEC: 06 Jan 2026, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 29 Dec 2025
Transactions: 2
Transaction value: -$488,317
Accepted by SEC: 30 Dec 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 22 Dec 2025
Transactions: 2
Transaction value: -$483,672
Accepted by SEC: 22 Dec 2025, 16:10
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 15 Dec 2025
Transactions: 2
Transaction value: -$483,729
Accepted by SEC: 17 Dec 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 08 Dec 2025
Transactions: 4
Transaction value: -$477,163
Accepted by SEC: 09 Dec 2025, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 01 Dec 2025
Transactions: 2
Transaction value: -$463,794
Accepted by SEC: 02 Dec 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 24 Nov 2025
Transactions: 3
Transaction value: -$451,814
Accepted by SEC: 24 Nov 2025, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 Nov 2025
Transactions: 2
Transaction value: -$427,957
Accepted by SEC: 19 Nov 2025, 12:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 10 Nov 2025
Transactions: 2
Transaction value: -$426,193
Accepted by SEC: 12 Nov 2025, 16:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 03 Nov 2025
Transactions: 6
Transaction value: -$413,216
Accepted by SEC: 04 Nov 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Oct 2025
Transactions: 3
Transaction value: -$388,429
Accepted by SEC: 29 Oct 2025, 09:20
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Oct 2025
Transactions: 2
Transaction value: -$374,081
Accepted by SEC: 22 Oct 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Oct 2025
Transactions: 3
Transaction value: -$362,964
Accepted by SEC: 14 Oct 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Oct 2025
Transactions: 2
Transaction value: -$358,614
Accepted by SEC: 07 Oct 2025, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 01 Oct 2025
Transactions: 3
Transaction value: -$350,957
Accepted by SEC: 02 Oct 2025, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 23 Sep 2025
Transactions: 1
Transaction value: -$356,290
Accepted by SEC: 24 Sep 2025, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 17 Sep 2025
Transactions: 2
Transaction value: -$356,367
Accepted by SEC: 18 Sep 2025, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 26 Dec 2023
Transactions: 2
Transaction value: -$462,547
Accepted by SEC: 27 Dec 2023, 18:30
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Dec 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Dec 2023, 17:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 Dec 2023
Transactions: 2
Transaction value: -$446,099
Accepted by SEC: 20 Dec 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 11 Dec 2023
Transactions: 2
Transaction value: -$420,304
Accepted by SEC: 13 Dec 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 04 Dec 2023
Transactions: 2
Transaction value: -$417,678
Accepted by SEC: 06 Dec 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Nov 2023
Transactions: 2
Transaction value: -$410,868
Accepted by SEC: 01 Dec 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 20 Nov 2023
Transactions: 2
Transaction value: -$424,806
Accepted by SEC: 22 Nov 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Nov 2023
Transactions: 2
Transaction value: -$419,861
Accepted by SEC: 16 Nov 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Nov 2023
Transactions: 2
Transaction value: -$421,246
Accepted by SEC: 09 Nov 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 30 Oct 2023
Transactions: 2
Transaction value: -$401,604
Accepted by SEC: 01 Nov 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 24 Oct 2023
Transactions: 2
Transaction value: -$391,216
Accepted by SEC: 27 Oct 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 17 Oct 2023
Transactions: 2
Transaction value: -$391,638
Accepted by SEC: 19 Oct 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 10 Oct 2023
Transactions: 2
Transaction value: -$397,939
Accepted by SEC: 12 Oct 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 03 Oct 2023
Transactions: 2
Transaction value: -$427,607
Accepted by SEC: 05 Oct 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 26 Sep 2023
Transactions: 2
Transaction value: -$432,935
Accepted by SEC: 28 Sep 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 Sep 2023
Transactions: 2
Transaction value: -$459,006
Accepted by SEC: 20 Sep 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 12 Sep 2023
Transactions: 2
Transaction value: -$438,712
Accepted by SEC: 13 Sep 2023, 17:00
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 05 Sep 2023
Transactions: 1
Transaction value: -$475,939
Accepted by SEC: 06 Sep 2023, 16:10
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 28 Aug 2023
Transactions: 2
Transaction value: -$473,188
Accepted by SEC: 30 Aug 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 22 Aug 2023
Transactions: 1
Transaction value: -$473,981
Accepted by SEC: 23 Aug 2023, 16:10
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 14 Aug 2023
Transactions: 1
Transaction value: -$485,495
Accepted by SEC: 15 Aug 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 07 Aug 2023
Transactions: 1
Transaction value: -$496,034
Accepted by SEC: 08 Aug 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 01 Aug 2023
Transactions: 2
Transaction value: -$443,030
Accepted by SEC: 03 Aug 2023, 16:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 24 Jul 2023
Transactions: 2
Transaction value: -$453,074
Accepted by SEC: 26 Jul 2023, 20:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 17 Jul 2023
Transactions: 1
Transaction value: -$456,983
Accepted by SEC: 18 Jul 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 11 Jul 2023
Transactions: 2
Transaction value: -$463,480
Accepted by SEC: 13 Jul 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 05 Jul 2023
Transactions: 2
Transaction value: -$458,613
Accepted by SEC: 07 Jul 2023, 16:15
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Jun 2023
Transactions: 2
Transaction value: -$478,659
Accepted by SEC: 28 Jun 2023, 17:05
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 20 Jun 2023
Transactions: 2
Transaction value: -$484,034
Accepted by SEC: 21 Jun 2023, 16:30
Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 12 Jun 2023
Transactions: 1
Transaction value: -$473,552
Accepted by SEC: 12 Jun 2023, 17:48
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Jun 2023
Transactions: 1
Transaction value: -$467,756
Accepted by SEC: 08 Jun 2023, 09:15
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 30 May 2023
Transactions: 2
Transaction value: -$462,905
Accepted by SEC: 01 Jun 2023, 11:02
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 22 May 2023
Transactions: 1
Transaction value: -$459,507
Accepted by SEC: 23 May 2023, 11:56
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 15 May 2023
Transactions: 2
Transaction value: -$459,603
Accepted by SEC: 16 May 2023, 16:04
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 09 May 2023
Transactions: 2
Transaction value: -$468,794
Accepted by SEC: 11 May 2023, 11:49
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 05 May 2023
Transactions: 1
Transaction value: -$461,976
Accepted by SEC: 08 May 2023, 18:40
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 24 Apr 2023
Transactions: 1
Transaction value: -$412,324
Accepted by SEC: 24 Apr 2023, 19:27
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 17 Apr 2023
Transactions: 1
Transaction value: -$396,925
Accepted by SEC: 17 Apr 2023, 16:56
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 10 Apr 2023
Transactions: 1
Transaction value: -$402,577
Accepted by SEC: 11 Apr 2023, 12:09
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 03 Apr 2023
Transactions: 1
Transaction value: -$387,066
Accepted by SEC: 03 Apr 2023, 17:52
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Mar 2023
Transactions: 1
Transaction value: -$381,082
Accepted by SEC: 29 Mar 2023, 12:41
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 20 Mar 2023
Transactions: 1
Transaction value: -$374,530
Accepted by SEC: 21 Mar 2023, 18:21
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Mar 2023
Transactions: 1
Transaction value: -$378,117
Accepted by SEC: 15 Mar 2023, 10:35
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Mar 2023
Transactions: 2
Transaction value: -$386,826
Accepted by SEC: 07 Mar 2023, 16:53
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Feb 2023
Transactions: 2
Transaction value: -$377,831
Accepted by SEC: 28 Feb 2023, 12:40
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Feb 2023
Transactions: 1
Transaction value: -$367,500
Accepted by SEC: 22 Feb 2023, 17:26
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Feb 2023
Transactions: 1
Transaction value: -$355,000
Accepted by SEC: 14 Feb 2023, 15:04
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Feb 2023
Transactions: 1
Transaction value: -$355,000
Accepted by SEC: 14 Feb 2023, 11:05
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 03 May 2022
Transactions: 1
Transaction value: -$335,298
Accepted by SEC: 04 May 2022, 19:10
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Apr 2022
Transactions: 1
Transaction value: -$404,996
Accepted by SEC: 28 Apr 2022, 17:32
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 19 Apr 2022
Transactions: 1
Transaction value: -$439,023
Accepted by SEC: 21 Apr 2022, 07:43
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 12 Apr 2022
Transactions: 1
Transaction value: -$429,012
Accepted by SEC: 13 Apr 2022, 17:46
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 07 Apr 2022
Transactions: 1
Transaction value: -$453,530
Accepted by SEC: 08 Apr 2022, 16:08
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 28 Mar 2022
Transactions: 1
Transaction value: -$529,546
Accepted by SEC: 30 Mar 2022, 07:38
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Mar 2022
Transactions: 1
Transaction value: -$500,802
Accepted by SEC: 22 Mar 2022, 16:09
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 16 Mar 2022
Transactions: 1
Transaction value: -$466,547
Accepted by SEC: 17 Mar 2022, 07:39
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 07 Mar 2022
Transactions: 1
Transaction value: -$470,353
Accepted by SEC: 10 Mar 2022, 17:26
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 01 Mar 2022
Transactions: 1
Transaction value: -$492,554
Accepted by SEC: 03 Mar 2022, 17:04
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 25 Feb 2022
Transactions: 1
Transaction value: -$469,959
Accepted by SEC: 28 Feb 2022, 18:29
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 17 Feb 2022
Transactions: 1
Transaction value: -$471,506
Accepted by SEC: 22 Feb 2022, 15:10
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 07 Feb 2022
Transactions: 1
Transaction value: -$474,434
Accepted by SEC: 08 Feb 2022, 15:09
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 02 Feb 2022
Transactions: 1
Transaction value: -$394,417
Accepted by SEC: 04 Feb 2022, 15:43
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Jan 2022
Transactions: 1
Transaction value: -$370,559
Accepted by SEC: 28 Jan 2022, 15:09
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 Jan 2022
Transactions: 1
Transaction value: -$412,056
Accepted by SEC: 18 Jan 2022, 17:54
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 11 Jan 2022
Transactions: 1
Transaction value: -$445,379
Accepted by SEC: 13 Jan 2022, 15:06
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 04 Jan 2022
Transactions: 1
Transaction value: -$485,629
Accepted by SEC: 04 Jan 2022, 16:39
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Dec 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Jan 2022, 16:37
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 27 Dec 2021
Transactions: 1
Transaction value: -$471,073
Accepted by SEC: 28 Dec 2021, 15:35
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Dec 2021
Transactions: 1
Transaction value: -$443,800
Accepted by SEC: 22 Dec 2021, 15:41
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 13 Dec 2021
Transactions: 3
Transaction value: -$441,687
Accepted by SEC: 16 Dec 2021, 15:07
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 06 Dec 2021
Transactions: 1
Transaction value: -$443,706
Accepted by SEC: 08 Dec 2021, 15:19
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 29 Nov 2021
Transactions: 1
Transaction value: -$449,570
Accepted by SEC: 30 Nov 2021, 17:43
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 23 Nov 2021
Transactions: 1
Transaction value: -$403,150
Accepted by SEC: 24 Nov 2021, 17:01
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 07 Sep 2021
Transactions: 2
Transaction value: -$348,201
Accepted by SEC: 09 Sep 2021, 16:07
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 30 Aug 2021
Transactions: 2
Transaction value: -$335,734
Accepted by SEC: 01 Sep 2021, 21:46
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 23 Aug 2021
Transactions: 2
Transaction value: -$336,686
Accepted by SEC: 25 Aug 2021, 17:52
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 18 Aug 2021
Transactions: 2
Transaction value: -$332,972
Accepted by SEC: 20 Aug 2021, 16:51
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 09 Aug 2021
Transactions: 2
Transaction value: -$353,252
Accepted by SEC: 11 Aug 2021, 17:43
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 03 Aug 2021
Transactions: 2
Transaction value: -$338,698
Accepted by SEC: 04 Aug 2021, 17:29
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 26 Jul 2021
Transactions: 2
Transaction value: -$345,550
Accepted by SEC: 28 Jul 2021, 11:30
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 19 Jul 2021
Transactions: 2
Transaction value: -$339,500
Accepted by SEC: 21 Jul 2021, 18:06
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 16 Jul 2021
Transactions: 1
Transaction value: -$641,820
Accepted by SEC: 19 Jul 2021, 17:38
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 09 Jul 2021
Transactions: 1
Transaction value: -$30,355
Accepted by SEC: 09 Jul 2021, 18:36
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 28 Jun 2021
Transactions: 2
Transaction value: -$282,783
Accepted by SEC: 29 Jun 2021, 18:15
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 IRMD

IRADIMED CORP

Report period: 21 Jun 2021
Transactions: 3
Transaction value: -$278,695
Accepted by SEC: 23 Jun 2021, 19:13
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .